苏州医药产业集群创新发展路径研究

Research on Innovative Development Path of Suzhou Pharmaceutical Industry Cluster

医药产业是国家重点培育发展的战略性新兴产业。新冠疫情爆发引起全球各国对医药产业的重视。中国多地出台政策,将其作为重点发展产业。苏州是江苏医药产业的重要集聚区之一,也是医药创新的重要载体。文章梳理和分析了苏州医药产业发展特点,在全球医药大背景下,结合当前相关最新研究成果,提出苏州医药产业集群创新发展与量质提升的路径,从理论和实践两个方面为当前各地医药产业集群的发展提供参考。

The pharmaceutical industry is a strategic emerging industry that the country focuses.The outbreak of the coronavirus disease has aroused the attention of countries around the world to the pharmaceutical industry.China has issued policies in many places,making them the focus of industrial development.Suzhou is one of the important clusters of Jiangsu's pharmaceutical industry and an important carrier of pharmaceutical innovation.In April 2020,Suzhou proposed to build the biomedical industry into Suzhou's most representative,competitive and commanding heights by 2030,and become the most recognizable industry landmark in the world.This article combs and analyzes the characteristics of the development of Suzhou's pharmaceutical industry.In the context of global pharmaceuticals,combined with the current relevant latest research results,this paper proposes a path for the innovation and development of Suzhou pharmaceutical industry clusters and the improvement of quantity and quality.It provides references for the current development of medical clusters in various regions from both theoretical and practical perspective.